| Discovery, development, and patent trends on Molnupiravir: A prospective oral treatment for COVID-19 M Imran, M Kumar Arora, SMB Asdaq, SA Khan, SI Alaqel, ... Molecules 26 (19), 5795, 2021 | 186 | 2021 |
| An updated review: newer quinazoline derivatives under clinical trial. Abida, P Nayyar, R Arpana, I Mohd International journal of pharmaceutical and biological archives 2 (6), 1651-1657, 2011 | 61 | 2011 |
| The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature M Imran, HK Thabet, SI Alaqel, AR Alzahrani, A Abida, MK Alshammari, ... Antioxidants 11 (5), 876, 2022 | 49 | 2022 |
| Solubility and thermodynamic/solvation behavior of 6-phenyl-4, 5-dihydropyridazin-3 (2H)-one in different (Transcutol+ water) mixtures F Shakeel, M Imran, Abida, N Haq, FK Alanazi, IA Alsarra Journal of Molecular Liquids 230, 511-517, 2017 | 41 | 2017 |
| Stability indicating RP-HPLC method development and validation for oseltamivir API B Narasimhan, K Abida, K Srinivas Chemical and Pharmaceutical Bulletin 56 (4), 413-417, 2008 | 41 | 2008 |
| Synthetic molecules as DprE1 inhibitors: A patent review M Imran, A AS, HK Thabet, Abida, M Afroz Bakht Expert opinion on therapeutic patents 31 (8), 759-772, 2021 | 35 | 2021 |
| Innovations and patent trends in the development of USFDA approved protein kinase inhibitors in the last two decades M Imran, SMB Asdaq, SA Khan, D Unnikrishnan Meenakshi, AS Alamri, ... Pharmaceuticals 14 (8), 710, 2021 | 33 | 2021 |
| Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review M Imran, AS Alshrari, SMB Asdaq, Abida Journal of Infection and Public Health 14 (8), 1075-1086, 2021 | 30 | 2021 |
| Discovery of novel pyridazine-based cyclooxygenase-2 inhibitors with a promising gastric safety profile A Khan, A Diwan, HK Thabet, M Imran, M Bakht Molecules 25 (9), 2002, 2020 | 26 | 2020 |
| Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature M Imran, SA Khan, Abida, MK Alshammari, SM Alkhaldi, FN Alshammari, ... Molecules 27 (9), 2750, 2022 | 21 | 2022 |
| Synthesis and Antimicrobial Activity of Some 2-Amino-4-(7-Substituted/Unsubstituted Coumarin-3-yl)-6-(Chlorosubstitutedphenyl) Pyrimidines M Imran, Abida, K Suroor, Ahmad Tropical Journal of Pharmaceutical Research 14 (7), 1265-1272, 2015 | 21 | 2015 |
| Mucormycosis medications: a patent review M Imran, A AS, M Tauseef, SA Khan, SA Hudu, Abida Expert opinion on therapeutic patents 31 (11), 1059-1074, 2021 | 19 | 2021 |
| Synthesis and evaluation of antimicrobial activity of some 2-morpholinomethylamino-4-(7-unsubstituted/substituted coumarin-3-yl)-6-chlorosubstitutedphenyl pyrimidines Abida, M Imran, AJ Alsalman Tropical Journal of Pharmaceutical Research 15 (2), 393-404, 2016 | 15 | 2016 |
| Tectona grandis Lf: A comprehensive review on its patents, chemical constituents, and biological activities SMB Asdaq, N Nayeem, MT Alam, SI Alaqel, M Imran, EWE Hassan, ... Saudi Journal of Biological Sciences 29 (3), 1456-1464, 2022 | 13 | 2022 |
| Small molecules as kinetoplastid specific proteasome inhibitors for Leishmaniasis: A patent review from 1998 to 2021 M Imran, SA Khan, Abida, AS Alshrari, MM Eltahir Mudawi, ... Expert Opinion on Therapeutic Patents 32 (5), 591-604, 2022 | 12 | 2022 |
| Synthesis of novel N‐substitutedphenyl‐6‐oxo‐3‐phenylpyridazine derivatives as cyclooxygenase‐2 inhibitors A Khan, A Diwan, HK Thabet, M Imran Drug Development Research 81 (5), 573-584, 2020 | 12 | 2020 |
| Antimicrobial Activities of Various Thiazine Based Heterocyclic Compounds: A Mini-Review M Asif, M Imran, Abida Mini-Reviews in Organic Chemistry 19 (2), 166-172, 2022 | 11 | 2022 |
| Solubilization and thermodynamic properties of simvastatin in various micellar solutions of different non-ionic surfactants: Computational modeling and solubilization capacity F Shakeel, S Alshehri, MA Ibrahim, M Altamimi, N Haq, EM Elzayat, ... PLoS One 16 (4), e0249485, 2021 | 11 | 2021 |
| 6-(4-Aminophenyl)-4, 5-dihydro-3 (2H)-pyridazinone-an important chemical moiety for development of cardioactive agents: A review M Imran, A Abida Tropical Journal of Pharmaceutical Research 15 (7), 1579-1590, 2016 | 11 | 2016 |
| Oral Brincidofovir Therapy For Monkeypox Outbreak: A Fo-cused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects. A Imran M Biomedicines 11 (2), 278, 2023 | 9 | 2023 |
